*P04.009 at EASO 2025 (European Association for the Study of Obesity) is a meta-analysis presented at the European Congress on Obesity (ECO) 2025 examining weight regain after stopping GLP-1 receptor agonists (RAs) for weight management
(2005) (2 R)-4-Oxo-4-[3-(trifluoromethyl)-5, 6-dihydro [1, 2, 4] triazolo [4, 3-a] pyrazin-7 (8 H)-yl]-1-(2, 4, 5-trifluorophenyl) butan-2-amine: a Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Cantudo-Sanagustn E, Gutirrez-Corrales A, Vigo-Martnez M, Serrera-Figallo M, Torres-Lagares D, Gutirrez-Prez JL
Haz tu pedido hoy mismo y comienza a transformar tu bienestar
M.PachikianB